In the current experiments, we set about to examine the regulatory effects that IGF2BP2 on GBM cell chemoresistance and analyze the potential regulatory network of the IGF2BP2/DANCR/FOXO1/PID1, aiming to provide a novel antitumor target for tumor treatment. The gene discussed is FOXO1; the disease is glioblastoma.